Please check your internet connection and try again.
# Diadzein + Genistein + Palmitoylethanolamide
## Overview
This combination product contains Diadzein, Genistein, and Palmitoylethanolamide (PEA). Diadzein and Genistein are isoflavones found in soybeans, often used for menopausal symptoms and general health. Palmitoylethanolamide is an endogenous fatty acid amide with potential anti-inflammatory and analgesic properties.
## Primary Indications
This combination is typically marketed as a dietary supplement. There are no FDA-approved indications for this specific combination product. Individual components have been studied for:
* **Diadzein and Genistein:** Menopausal symptom management (e.g., hot flashes), bone health, cardiovascular health.
* **Palmitoylethanolamide:** Chronic pain, inflammatory conditions.
## Adult Dosing
Dosing for this combination product is not standardized and varies by manufacturer and product formulation. Follow product-specific recommendations or healthcare provider guidance. Typical daily intake ranges for individual components are:
* **Diadzein:** 10-50 mg per day.
* **Genistein:** 10-50 mg per day.
* **Palmitoylethanolamide (PEA):** 300-1200 mg per day, often divided into multiple doses.
## Pediatric Dosing
There is no established pediatric dosing for this combination product. Use in pediatric populations is not recommended without explicit guidance from a qualified healthcare provider.
## Dose Adjustments
No specific dose adjustments are established for hepatic or renal impairment for this combination.
## Contraindications
* Hypersensitivity to any component of the product.
* Pregnancy and breastfeeding: Due to lack of safety data, use is generally not recommended.
## Adverse Effects
Adverse effects are typically mild and may include gastrointestinal upset (nausea, bloating, diarrhea). Specific effects related to isoflavones and PEA may overlap with those of their individual use.
## Key Drug Interactions
* **Hormone-sensitive conditions:** Isoflavones (Diadzein, Genistein) may have weak estrogenic effects. Caution is advised in patients with a history of hormone-sensitive cancers (e.g., breast, uterine) or conditions like endometriosis.
* **Anticoagulants/Antiplatelets:** Potential for additive effects, though not well-established.
* **CYP450 Substrates:** Theoretical interactions may exist with isoflavones, though clinical significance is unclear.
## Monitoring
* Monitor for signs and symptoms of gastrointestinal upset.
* For patients with hormone-sensitive conditions, monitor for any changes or concerns related to their condition.
## Clinical Pearls
* This product is generally considered a dietary supplement, not a pharmaceutical.
* Efficacy and safety for the combination product are not well-established through rigorous clinical trials.
* Individual response to isoflavones can vary based on gut microbiome metabolism.
***
*Disclaimer: This information is intended for educational purposes only and does not substitute professional medical advice. Always consult with a qualified healthcare provider to determine what is best for your unique situation. It is essential to review the most current prescribing information and consult with a pharmacist or physician before making any decisions about medication or treatment.*
